Shanghai Kaibao Pharmaceutical CO.,Ltd (SHE:300039)
China flag China · Delayed Price · Currency is CNY
6.46
+0.06 (0.94%)
At close: Mar 10, 2026

SHE:300039 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2019 - 2015
Cash & Equivalents
778.83593.31601.94694.691,3451,307
Upgrade
Short-Term Investments
662.99924.87--58.3236.13
Upgrade
Trading Asset Securities
197.81180.02150.01136.0751.26114.65
Upgrade
Cash & Short-Term Investments
1,6401,698751.95830.761,4551,458
Upgrade
Cash Growth
23.89%125.84%-9.49%-42.88%-0.23%8.09%
Upgrade
Accounts Receivable
351.65471.99529.32530.33567.99528.76
Upgrade
Other Receivables
0.4234.5110.3435.7746.7732.32
Upgrade
Receivables
352.07506.51539.67566.09614.76562.39
Upgrade
Inventory
199.05187.85171.79160.8165.14191.54
Upgrade
Other Current Assets
39.9122.8111.4716.7719.998.08
Upgrade
Total Current Assets
2,2312,4151,4751,5742,2542,220
Upgrade
Property, Plant & Equipment
259.41267.85290.09304.66307.78295.87
Upgrade
Long-Term Investments
1,3901,6242,7301,312711.06280.24
Upgrade
Goodwill
---9.0413.7918.5
Upgrade
Other Intangible Assets
164.9168.845.1144.2342.945.26
Upgrade
Long-Term Deferred Tax Assets
26.4829.4431.6118.2615.117.55
Upgrade
Long-Term Deferred Charges
2.932.440.210.32--
Upgrade
Other Long-Term Assets
884.1711.037.64996.4910.75-
Upgrade
Total Assets
4,9584,5184,5804,2593,3562,877
Upgrade
Accounts Payable
104.9999.37134.8591.0175.0262.23
Upgrade
Accrued Expenses
4.7426.4623.2729.6915.9213.47
Upgrade
Short-Term Debt
4.175.42---35.72
Upgrade
Current Income Taxes Payable
38.1831.6241.0835.543.478.82
Upgrade
Current Unearned Revenue
13.8418.2945.6940.042.881.75
Upgrade
Other Current Liabilities
14.0851.1589.9699.6793.39115.56
Upgrade
Total Current Liabilities
180232.3334.85295.96190.68237.55
Upgrade
Long-Term Unearned Revenue
48.4348.0343.2639.5147.1651.53
Upgrade
Long-Term Deferred Tax Liabilities
184.13135.11168.71162.7773.069.88
Upgrade
Total Liabilities
412.55415.45546.82498.24310.9298.96
Upgrade
Common Stock
1,0461,0461,0461,0461,0461,046
Upgrade
Additional Paid-In Capital
8.628.628.628.628.628.62
Upgrade
Retained Earnings
2,4882,3232,0501,7851,5771,468
Upgrade
Comprehensive Income & Other
1,002724.5926.33921.98413.5355.68
Upgrade
Total Common Equity
4,5454,1024,0313,7623,0452,578
Upgrade
Minority Interest
0.60.971.64-0.72-0-
Upgrade
Shareholders' Equity
4,5464,1034,0333,7613,0452,578
Upgrade
Total Liabilities & Equity
4,9584,5184,5804,2593,3562,877
Upgrade
Total Debt
4.175.42---35.72
Upgrade
Net Cash (Debt)
1,6351,693751.95830.761,4551,422
Upgrade
Net Cash Growth
23.85%125.12%-9.49%-42.88%2.28%5.44%
Upgrade
Net Cash Per Share
1.561.620.720.791.391.36
Upgrade
Filing Date Shares Outstanding
1,0461,0461,0461,0461,0461,046
Upgrade
Total Common Shares Outstanding
1,0461,0461,0461,0461,0461,046
Upgrade
Working Capital
2,0512,1831,1401,2782,0641,982
Upgrade
Book Value Per Share
4.353.923.853.602.912.46
Upgrade
Tangible Book Value
4,3803,9333,9863,7082,9882,515
Upgrade
Tangible Book Value Per Share
4.193.763.813.552.862.40
Upgrade
Buildings
-386.31383.04372.25342.91342.42
Upgrade
Machinery
-425.35441.06427.9407.9400.23
Upgrade
Construction In Progress
-1.230.526.1834.151.99
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.